Shanghai Xuerong Bio-Technology Co (SZSE:300511) Long-Term Capital Lease Obligation : ¥18 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Shanghai Xuerong Bio-Technology Co Long-Term Capital Lease Obligation?

Shanghai Xuerong Bio-Technology Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥18 Mil.

Shanghai Xuerong Bio-Technology Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (¥23 Mil) to Dec. 2023 (¥24 Mil) but then declined from Dec. 2023 (¥24 Mil) to Mar. 2024 (¥18 Mil).

Shanghai Xuerong Bio-Technology Co's annual Long-Term Capital Lease Obligation stayed the same from Dec. 2021 (¥23 Mil) to Dec. 2022 (¥23 Mil) but then increased from Dec. 2022 (¥23 Mil) to Dec. 2023 (¥24 Mil).

Shanghai Xuerong Bio-Technology Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Shanghai Xuerong Bio-Technology Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Xuerong Bio-Technology Co Long-Term Capital Lease Obligation Chart

Shanghai Xuerong Bio-Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

24.83

23.45

24.42

Shanghai Xuerong Bio-Technology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															27.18	23.24	23.22	24.42	18.03

Shanghai Xuerong Bio-Technology Co (SZSE:300511) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Shanghai Xuerong Bio-Technology Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shanghai Xuerong Bio-Technology Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Xuerong Bio-Technology Co (SZSE:300511) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Shanghai Xuerong Bio-Technology Co Ltd (SZSE:300511) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

No 999 Gaofeng Road, Modern Agriculture Park, Fengxian District, Shanghai, CHN, 201401

Website

http://www.xuerong.com

Shanghai Xuerong Bio-Technology Co Ltd is a bio-agricultural company, engages in the research, production, and marketing of edible fungi primarily in the People's Republic of China. It offers various mushroom products, such as white enoki, white-shimeji, brown-shimeji, seafood mushroom, king crab mushroom, king oyster mushroom, pleurotus nebrodensis, agaricus bisporus, and shiitake.

Executives

Yang Yong Ping	Directors, executives
Chen Xin	Directors, executives
Zhu Huan Cheng	Directors, executives
Yu Rong Lin	Directors, executives
Ding Qiang	Directors, Directors, and Executives
Gu Yong Kang	Securities Affairs Representative

Shanghai Xuerong Bio-Technology Co (SZSE:300511) Headlines

No Headlines